Get real time update about this post category directly on your device, subscribe now.
Hyderabad: For those who are still a tad hesitant in taking the Covaxin jab, there’s reassuring news. The phase 3 interim analysis of the Bharat Biotech-manufactured coronavirus vaccine was announced...
Read moreDetailsRaipur/Bhopal: The Chhattisgarh and Madhya Pradesh governments are the latest states to announce that they will bear expenses of COVID-19 vaccination of everyone in the state above the age of...
Read moreDetailsKolkata: Journalists are not considered to be frontline workers, hence they are not among the central government’s priority group for vaccination. In a praiseworthy initiative, Kolkata Press Club in association...
Read moreDetailsNew Delhi: Besides opening up vaccination for those above 18 years from May 1, the Centre took several other important decisions at a meeting on Monday chaired by Prime Minister...
Read moreDetailsBhubaneswar: Odisha is set to receive another two lakh doses of Covishield vaccine by today night, informed Director, Health & Family Welfare, Bijay Panigrahi. The Health Director hoped that the...
Read moreDetailsA single or double dose vaccine may not be enough to be safe from coronavirus. If Pfizer CEO Albert Bourla is to be believed, a booster shot may be required...
Read moreDetailsA rare blood clotting condition, after administration of the Oxford-AstraZeneca COVID vaccine, has been a cause of concern in the UK and other European Union countries. About 10 deaths have...
Read moreDetailsNew Delhi: The second wave of coronavirus infections in India has affected younger people more. In Delhi, as high as 65% of COVID-19 patients are under 45 years of age....
Read moreDetailsNew Delhi: Even as the second wave of COVID-19 pandemic surpasses all previous figures in India, the country is continuing with its vaccination drive at an impressive pace compared to...
Read moreDetailsWorld Health Organization (WHO) cited insufficient data in rejecting the proposal of Serum Institute of India (SII), seeking extension of shelf life of Oxford-AstraZeneca’s COVID-19 vaccine, Covishield, from six to...
Read moreDetails